Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2026)

Rigel Pharmaceuticals' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.09 for Q1 2026.

• In Q1 2026, Debt Ratio fell 73.82% year-over-year to 0.09; the TTM figure through Mar 2026 stood at 0.09 (down 73.82% YoY), while the FY2025 annual figure was 0.16, down 60.85% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.09, down from 0.16 in the prior quarter.
• The five-year high for Debt Ratio was 0.52 in Q3 2023, with the low at 0.09 in Q1 2026.
• The 5-year median for Debt Ratio is 0.34 (2022), against an average of 0.35.
• The sharpest annual moves came in 2022 and 2026: Debt Ratio soared 220.19% in 2022, then tumbled 73.82% in 2026.
• Rigel Pharmaceuticals' Debt Ratio stood at 0.29 in 2022, then surged by 73.07% to 0.51 in 2023, then declined by 19.69% to 0.41 in 2024, then sank by 60.85% to 0.16 in 2025, then slumped by 44.4% to 0.09 in 2026.
• Business Quant data shows RIGL's Debt Ratio at 0.09 in Q1 2026, 0.16 in Q4 2025, and 0.25 in Q3 2025.